MRI能否用于检测临床静止性复发性软组织肉瘤
回顾性分析23例复发与22例无复发的高级别软组织肉瘤患者的MRI,比较常规MRI、动态对比增强MRI及结合手术切缘知识对复发的诊断效能。联合三者时鉴别复发与治疗后改变效能最高(AUC 0.779),其次为DCE-MRI(AUC 0.706)和常规MRI(AUC 0.648)。MRI技术不充分和将显微镜下切缘阳性后的治疗后改变过度判读分别是假阴性和假阳性的主要原因。
要点
- 结合手术切缘知识可提高MRI检测临床静止性复发的效能(AUC 0.779)。
- DCE-MRI有助于鉴别复发与治疗后纤维化(AUC 0.706)。
- MRI方案不充分可导致漏诊复发。
核心结论
- 联合常规MRI、DCE-MRI及手术切缘知识时,鉴别复发与治疗后改变的效能最高(AUC 0.779)。
- MRI方案不充分时可能漏诊局部复发。
研究设计与样本
- 回顾性分析23例(12名男性;平均年龄59.7岁±16.5岁)复发软组织肉瘤患者与22例年龄和组织学匹配的无复发对照的MRI。
- 由两名骨肌放射科医生分析术前及治疗后但证实复发前的MRI特征(常规和DCE),并分别评估形态学和动态评估的复发可能性(5点Likert量表),以及在添加手术切缘知识前后的评估。
- 采用描述性统计和受试者工作特征分析。
关键影像表现/征象
- 常规MRI、DCE-MRI和手术切缘知识联合鉴别复发与治疗后改变的AUC为0.779。
- DCE-MRI单独鉴别复发与治疗后改变的AUC为0.706。
- 常规MRI单独鉴别复发与治疗后改变的AUC为0.648。
诊断标准与关键数值
- 采用5点Likert量表分别对形态学和动态评估的复发可能性进行评分,并在添加手术切缘知识前后分别评估。
- 常规MRI、DCE-MRI和手术切缘知识联合鉴别复发与治疗后改变的AUC为0.779。
- DCE-MRI鉴别复发与治疗后改变的AUC为0.706。
- 常规MRI鉴别复发与治疗后改变的AUC为0.648。
临床应用与阅片要点
- MRI方案应包含所有三个图像方向,至少一个序列覆盖整个肢体部分,并与初始肿瘤特征和位置比较,有益于检测复发。
- MRI技术不充分是假阴性结果的主要原因。
- 将显微镜下切缘阳性后的治疗后改变过度判读为复发是假阳性结果的主要原因。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The impact of MRI on early detection of local recurrence (LR) in high-grade soft-tissue sarcomas (STS) is unsubstantiated. To identify the contribution of MRI criteria including dynamic contrast-enhanced (DCE) MRI and knowledge of surgical margins that can be used in detecting recurrence prior to obvious proven presence of LR in soft-tissue sarcomas. The secondary aim was to determine causes for misdiagnosing LR.
METHODS: MRI of 23 patients (12 men; mean age, 59.7 years ± 16.5 years) with LR of STS and that of 22 age- and histology-matched controls with STS but without LR were retrospectively analyzed by two musculoskeletal radiologists. Preoperative MRI characteristics (conventional and DCE) were compared to those of MRIs made after treatment, but before LR was proven. Likelihood of recurrence was rated on a 5-point Likert scale for morphological and dynamic assessment separately, before and after adding knowledge of surgical margins. Descriptive statistics and receiver operating characteristic analysis were performed.
RESULTS: Differentiation of LR from post-therapeutic changes was the highest combining result of conventional MRI, DCE-MRI, and knowledge of surgical margins (area under the curve (AUC) 0.779), followed by DCE-MRI (AUC 0.706) and conventional MRI (AUC 0.648). Suboptimal MRI technique and overcalling post-therapeutic changes in microscopic positive margins were the main reasons for false negative and false positive results, respectively.
CONCLUSION: MRI including DCE improves the detection of recurrent, clinically silent soft-tissue sarcoma when combined with knowledge of achieved surgical margins. LR may be missed on inadequate MRI protocols.
KEY POINTS: • Dynamic contrast-enhanced MRI is useful in the differentiation of recurrent soft-tissue sarcoma and post-therapeutic fibrosis. • Knowledge of surgical margins substantially increases the value of MRI in detecting recurrent soft-tissue sarcoma. • MR with all three image orientations, covering the entire part of the extremity in at least one sequence and comparison to initial tumor characteristics and location, is beneficial.
引用
- Hirschmann A, van Praag VM, Haas RL, et al. Can we use MRI to detect clinically silent recurrent soft-tissue sarcoma? Eur Radiol. 2020. PMID: 32314057. doi:10.1007/s00330-020-06810-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。